Children and Adolescents

From Science of Us: Over the past few months, multiple studies have linked frequent nightmares to increased risk for both suicidality and self-harm. Article →­

Researchers from the University of Toronto departments of Psychiatry and Pharmacology, publishing in Progress in Neuro-Psychopharmacology and Biological Psychiatry, propose that various forms of stress,...

In an Op-Ed in the New York Times, Frank Bruni weighs in on the “concussion crisis,” and the long-term effects that sports-related brain injuries...

In this piece for Aeon, Bonnie Evans chronicles the history of the diagnosis of autism, from its establishment as a marker of dysfunction and impairment to the...

Last week, after the US Preventative Services Task Force (USPSTF) made a recommendation for increased mental health and depression screening “stories in the New York Times,...

BPS releases report encouraging behavioral interventions for people with dementia, rather than antipsychotics

A new article explains common misconceptions about ADHD that are held by teachers and mental health professionals and may lead to overdiagnosis and overmedication in schools.

Amidst a reported leveling in medication usage among young children, a disturbing side trend has emerged. Antipsychotic medication use in preschoolers has soared over the past decade, to the upwards tale of a two- to five- fold increase despite lack of FDA approval in almost all of these medications for this age group and little to no information about long-term side effects. In addition, researchers have noted that most antipsychotic medications were being used off-label, and increasingly for the treatment of behavioral issues that many argue are both developmentally inherent and often a product of significant environmental dysfunction.

After a number of years with a steadily increasing sales curve, the number of children and adolescents in treatment with depression pills decreased by 41% in Denmark. Despite this welcome development, pharmaceutical companies and psychiatry professors continue to deceive the population and deny the facts about these drugs.

A combined mindfulness and behavioral activation intervention is shown to reduce depressive symptoms and serve as a preventative factor for major depressive disorder.